Medtronic EBITDA 2010-2025 | MDT

Medtronic annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Medtronic EBITDA for the quarter ending January 31, 2025 was $2.329B, a 9.24% increase year-over-year.
  • Medtronic EBITDA for the twelve months ending January 31, 2025 was $8.247B, a 1.01% decline year-over-year.
  • Medtronic 2024 annual EBITDA was $7.792B, a 4.77% decline from 2023.
  • Medtronic 2023 annual EBITDA was $8.182B, a 3.29% decline from 2022.
  • Medtronic 2022 annual EBITDA was $8.46B, a 17.73% increase from 2021.
Medtronic Annual EBITDA
(Millions of US $)
2024 $7,792
2023 $8,182
2022 $8,460
2021 $7,186
2020 $7,454
2019 $8,927
2018 $9,284
2017 $8,300
2016 $8,210
2015 $5,148
2014 $4,671
2013 $5,678
2012 $5,666
2011 $5,272
2010 $5,653
2009 $4,686
Medtronic Quarterly EBITDA
(Millions of US $)
2025-01-31 $2,329
2024-10-31 $2,269
2024-07-31 $1,942
2024-04-30 $1,707
2024-01-31 $2,132
2023-10-31 $2,012
2023-07-31 $1,941
2023-04-30 $2,246
2023-01-31 $2,070
2022-10-31 $2,074
2022-07-31 $1,792
2022-04-30 $2,360
2022-01-31 $2,331
2021-10-31 $2,239
2021-07-31 $1,530
2021-04-30 $2,288
2021-01-31 $1,955
2020-10-31 $1,601
2020-07-31 $1,342
2020-04-30 $988
2020-01-31 $2,302
2019-10-31 $2,022
2019-07-31 $2,142
2019-04-30 $2,613
2019-01-31 $2,217
2018-10-31 $2,195
2018-07-31 $1,902
2018-04-30 $2,592
2018-01-31 $2,102
2017-10-31 $2,572
2017-07-31 $2,018
2017-04-30 $2,381
2017-01-31 $1,884
2016-10-31 $2,124
2016-07-31 $1,911
2016-04-30 $2,290
2016-01-31 $2,077
2015-10-31 $2,004
2015-07-31 $1,839
2015-04-30 $843
2015-01-31 $1,550
2014-10-31 $1,401
2014-07-31 $1,354
2014-04-30 $522
2014-01-31 $1,241
2013-10-31 $1,421
2013-07-31 $1,487
2013-04-30 $1,435
2013-01-31 $1,455
2012-10-31 $1,408
2012-07-31 $1,380
2012-04-30 $1,437
2012-01-31 $1,383
2011-10-31 $1,455
2011-07-31 $1,391
2011-04-30 $1,236
2011-01-31 $1,380
2010-10-31 $1,347
2010-07-31 $1,309
2010-04-30 $1,304
2010-01-31 $1,502
2009-10-31 $1,449
2009-07-31 $1,398
2009-04-30 $877
2009-01-31 $1,188
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $107.067B $32.364B
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.816B 27.87
Boston Scientific (BSX) United States $152.176B 38.10
Stryker (SYK) United States $145.393B 30.40
EssilorLuxottica (ESLOY) France $127.544B 0.00
Lonza Group Ag (LZAGY) Switzerland $50.941B 0.00
Haleon (HLN) United Kingdom $48.439B 27.54
ResMed (RMD) United States $35.929B 26.99
GE HealthCare Technologies (GEHC) United States $31.992B 15.19
Agilent Technologies (A) United States $30.486B 20.14
Terumo (TRUMY) Japan $28.205B 0.00
Koninklijke Philips (PHG) Netherlands $23.066B 16.58
Insulet (PODD) United States $21.859B 85.82
Zimmer Biomet Holdings (ZBH) United States $18.837B 12.10
Baxter (BAX) United States $15.857B 11.84
Smith & Nephew SNATS (SNN) United Kingdom $12.412B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $6.686B 22.60
Lantheus Holdings (LNTH) United States $5.598B 14.27
Prestige Consumer Healthcare (PBH) United States $4.325B 19.27
Perrigo (PRGO) Ireland $3.713B 9.41
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.426B 14.92
ICU Medical (ICUI) United States $3.404B 25.10
Envista Holdings (NVST) United States $2.981B 24.77
QuidelOrtho (QDEL) United States $2.451B 16.90
GN Store Nord (GNNDY) Denmark $2.075B 17.19
LeMaitre Vascular (LMAT) United States $1.813B 40.54
AtriCure (ATRC) United States $1.534B 0.00
Neogen (NEOG) United States $1.296B 16.58
Green Thumb Industries (GTBIF) United States $1.173B 26.38
Kestra Medical Technologies (KMTS) United States $1.164B 0.00
AdaptHealth (AHCO) United States $1.156B 11.75
BioLife Solutions (BLFS) United States $1.106B 0.00
InMode (INMD) Israel $1.005B 9.20
Phibro Animal Health (PAHC) United States $0.910B 11.64
Evolus (EOLS) United States $0.632B 0.00
CeriBell (CBLL) United States $0.575B 0.00
Curaleaf Holdings (CURLF) Canada $0.557B 0.00
Owens & Minor (OMI) United States $0.542B 4.49
Valneva SE (VALN) France $0.541B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.504B 0.00
Tilray Brands (TLRY) Canada $0.431B 0.00
Surmodics (SRDX) United States $0.383B 0.00
Omeros (OMER) United States $0.360B 0.00
Cresco Labs (CRLBF) United States $0.358B 0.00
SNDL (SNDL) Canada $0.339B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Capricor Therapeutics (CAPR) United States $0.290B 0.00
Sanara MedTech (SMTI) United States $0.288B 0.00
VAREX IMAGING (VREX) United States $0.283B 10.42
Aurora Cannabis (ACB) Canada $0.273B 48.50
Sanuwave Health (SNWV) United States $0.257B 0.00
Viemed Healthcare (VMD) United States $0.250B 21.07
Verano Holdings (VRNOF) United States $0.248B 0.00
Cerus (CERS) United States $0.247B 0.00
ZimVie (ZIMV) United States $0.244B 11.09
Canopy Growth (CGC) Canada $0.241B 0.00
Biote (BTMD) United States $0.219B 6.15
Quanterix (QTRX) United States $0.205B 0.00
High Tide (HITI) Canada $0.194B 0.00
OraSure Technologies (OSUR) United States $0.188B 0.00
Utah Medical Products (UTMD) United States $0.176B 14.18
Brainsway (BWAY) Israel $0.164B 51.24
TriSalus Life Sciences (TLSI) United States $0.162B 0.00
Organigram Global (OGI) Canada $0.158B 0.00
FitLife Brands (FTLF) United States $0.147B 18.16
Jin Medical (ZJYL) China $0.130B 0.00
TerrAscend (TSNDF) Canada $0.110B 0.00
Exagen (XGN) United States $0.103B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
MacroGenics (MGNX) United States $0.090B 0.00
Agape ATP (ATPC) $0.078B 0.00
Fonar (FONR) United States $0.077B 10.77
Veru (VERU) United States $0.074B 0.00
Jushi Holdings (JUSHF) United States $0.073B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.063B 0.00
United Health Products (UEEC) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Apyx Medical (APYX) United States $0.044B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Rockwell Medical (RMTI) United States $0.038B 56.00
United-Guardian (UG) United States $0.037B 12.79
Safety Shot (SHOT) United States $0.037B 0.00
Nephros (NEPH) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Senestech (SNES) United States $0.005B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00